Dementia Flashcards
What is the epidemiology of dementia?
Rare under 55yrs then increasingly common from then on
850,000 in UK in 2015, predicted >1 million by 2025
Alzheimer’s is the most common form
What is the aetiology and pathophysiology of Alzheimer’s disease?
May appear from 40yrs; even earlier in Down’s syndrome (inevitable)
Environmental and genetic factors
i) 1st degree relative
ii) Down’s
iii) Homozygosity for apolipoprotein e (Apoe) allele
iv) Vascular risk factors – raised BP, diabetes, hyperlipidaemia
v) Low physical/cognitive activity
vi) Depression and loneliness
vii) Smoking
Accumulation of ß-amyloid peptide (a degradation of amyloid protein) → progressive neuronal damage, neurofibrillary tangles, plaque formation, loss of ACh
i) Partly due to altered macrophage gene expression → reduced effective clearance
ii) Selective neuronal loss - hippocampus, amygdala, temporal neocortex
iii) Also show evidence of vascular dementia
What is the aetiology and pathophysiology of vascular dementia?
25% of all dementias
Represents the cumulative effect of many small strokes → sudden onset and stepwise deterioration is characteristic
Look for evidence of vascular pathology i.e. raised BP, past stroke, focal CNS signs
(Will not likely present with hallucinations)
What is the aetiology and pathophysiology of Lewy body dementia?
Characterised by histological presence of Lewy bodies in brainstem and neocortex (abnormal aggregates of protein)
What is the aetiology and pathophysiology of Fronto-temporal (Pick’s) dementia?
Frontal + temporal atrophy without Alzheimer’s histology
Genes on ch9 are important (as in MND)
What are some other aetiologies of dementia?
Alcohol/drug abuse Repeated head trauma Pellagra Whipples disease Huntingtons CJD Parkinson’s HIV
What’s the general presentation of all dementia’s?
Memory loss – over months/years (if hours = stroke, weeks = depression?)
Other cognitive function decline
Agitation, aggression, apathy
What is the presentation of Alzheimer’s disease?
Enduing progressive global cognitive impairment (other dementias are more focal) – reduction in visuospatial skills, memory, verbal abilities, executive function Anosognosia – lack of insight into the problems caused by the disease i.e. missed appointments, misunderstood conversations etc
Irritability, mood disturbance – euphoria, depression
Behavioural change – wandering, aggression
Psychosis – hallucination, delusion
Agnosia – cant recognise things, even self
Become sedentary in end stage
What is the presentation of Lewy body dementia?
Fluctuating cognitive impairment
Detailed visual hallucinations i.e. small animals or children
Parkinsonism
What is the presentation of Fronto-temporal dementia?
Also known as Pick’s disease
More common in those under 65yrs
Executive impairment
Behavioural/personality change
Early preservation of episodic memory and spatial orientation
Disinhibition - may seem like a bipolar manic presentation
Stereotyped behaviour
Emotional unconcern
Hyper-orality
Inability to produce speech and loss of literacy (primary progressive aphasia type)
How do you investigate dementia?
Good history from patient and family/friends etc -
timeline of symptoms established, failure to function?
Cognitive testing - AMTS or TYM, Mental state examination
Bloods, CT/MRI, ECG, genetics etc - to check for any potential remediable aetiologies
How do you manage dementia?
Incurable – progressive and terminal
Coordinated care with an MDT and family - Capacity? Future decisions? Plan ahead
Routines
Care for carers
Admiral nurses
Challenging behaviour or severe distress
i) Lorazepam
ii) Antipsychotics (though not for Lewy body or if Hx of Parkinson’s)
Antidepressants:
But not for mild/moderate depression
SSRIs are associated with hyponatraemia in the elderly = risky
Stop TCAs - can worsen cognitive impairment
Acetylcholinesterase inhibitors
i) Donepezil (not in those with bradycardia), Rivastigmine, Galantamine
ii) May improve some symptoms – help laying down of new memories rather than retention of old and delay need for institutional care
2nd line:
Memantine - an NDMA antagonist
For moderate Alzheimer’s in those who acetylcholinesterase inhibitors are contraindicated
Or as an adjunct to the above
Or in severe Alzheimer’s as a monotherapy